Exonic mutations associated with atopic dermatitis disrupt lympho‐epithelial Kazal‐type related inhibitor action and enhance its degradation
Abstract
Background: Skin desquamation is facilitated by serine proteases KLK5 and KLK7, which are tightly regulated by lympho‐epithelial Kazal‐type related inhibitor (LEKTI). LEKTI itself is controlled through degraded by mesotrypsin. Here, we sought to determine whether LEKTI exonic mutations associated with atopic dermatitis (AD) affect the protease inhibitory activity of LEKTI or its susceptibility to mesotrypsin degradation.Methods: The inhibitory activities of the LEKTI domain 4 (D4) and D6 WT and AD‐associated mutants on the enzyme activities of KLK5 and KLK7 were compared using fluorogenic substrates. A keratinocyte cell culture system using HaCat cells was established to assess the role of D6 WT and D386N on triggering inflammation via the induction of thymic stromal lymphopoietin (TSLP). A degradation assay was used to assess the susceptibility of D4 and D6 mutants to mesotrypsin degradation.Results: Enzymatic assays revealed that the D6 D386N mutation affected the inhibitory activity of LEKTI on KLK5 but not KLK7. Other exonic mutations on D6 (N368S, V395M, and E420K) and D4 (R267Q) did not alter LEKTI inhibition. The D386N mutation disrupted the role of D6 in suppressing TSLP induction by KLK5 in HaCat cells. Although WT D4 is more susceptible to mesotrypsin degradation than WT D6, the D4 R267Q mutant was more resistant to mesotrypsin degradation, whereas the D6 E420K mutant showed enhanced mesotrypsin‐mediated degradation.Conclusion: Exonic mutations in D6, which previously have been associated with AD, may cause a disruption of inhibitory activity on KLK5 or enhance the degradation by mesotrypsin.Keywords
Funding Information
- Ministry of Education - Singapore (MOE2011‐T2‐2‐002, R‐154‐000‐531‐112)
This publication has 35 references indexed in Scilit:
- Netherton syndrome: skin inflammation and allergy by loss of protease inhibitionCell and tissue research, 2013
- Distinct SPINK5 and IL-31 polymorphisms are associated with atopic eczema and non-atopic hand dermatitis in Taiwanese nursing populationExperimental Dermatology, 2011
- Kallikrein 5 induces atopic dermatitis–like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndromeJournal of Experimental Medicine, 2009
- LEKTI Fragments Specifically Inhibit KLK5, KLK7, and KLK14 and Control Desquamation through a pH-dependent InteractionMolecular Biology of the Cell, 2007
- Epidermal barrier formation and recovery in skin disordersJournal of Clinical Investigation, 2006
- Lack of association of SPINK5 polymorphisms with nonsyndromic atopic dermatitis in the population of Northern GermanyBritish Journal of Dermatology, 2005
- Polymorphisms in SPINK5 are not associated with asthma in a Dutch populationJournal of Allergy and Clinical Immunology, 2005
- LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndromeHuman Molecular Genetics, 2003
- Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLPNature Immunology, 2002
- Netherton Syndrome: Disease Expression and Spectrum of SPINK5 Mutations in 21 FamiliesJournal of Investigative Dermatology, 2002